Q3 Medical Group

Q3 Medical Group is a growth stage commercial company based in Dublin, Ireland leading innovations in biodegradable implants and micro invasive technology for Interventional Radiology, Gastro Intestinal, and open Surgical procedures. The company's mission is to provide better clinical outcomes and reduce the overall cost of care. The organization's wholly owned subsidiaries, QualiMed and Amg International, are focused on the development, approval, manufacturing, and sales of products, with a manufacturing site currently located in Winsen (Luhe), Germany and plans for a secondary site in China.

The company's lineup includes the ARCHIMEDES biodegradable Biliary and Pancreatic Stent, UNITY-B Endo/Perc biodegradable Balloon Expandable Biliary Stent System, Micro Invasive Technology, and Peripheral Vascular products. Q3 Medical Group has set ambitious growth plans, including establishing a 2nd Manufacturing Site - QSAN in China, achieving FDA Approval for Q3 USA, and the ultimate goal of an IPO. The company's slogan "Creating Value By Helping People" encapsulates its vision to become a global leader in creating, manufacturing, and selling innovative medical technology. The company's last investment was a Venture Round investment at 01 March 2017. Q3 Medical Group's dedication to revolutionizing healthcare through cutting-edge technology positions it as an attractive opportunity for investors seeking to make an impact in the Healthcare industry.